Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer

por Gökmen, İvo, Taştekin, Ebru, Demir, Nazan, Özcan, Erkan, Akgül, Fahri, Hacıoğlu, Muhammed Bekir, Erdoğan, Bülent, Topaloğlu, Sernaz, Çiçin, İrfan
Publicado 2023

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study

por Aydin, Sabin Goktas, Kavak, Engin Eren, Topcu, Atakan, Bayramgil, Ayberk, Akgul, Fahri, Kahraman, Seda, Aykan, Musa Baris, Altıntas, Yunus Emre, Helvaci, Kaan, Urun, Yuksel, Bilici, Ahmet, Seker, Mesut, Nahit Sendur, Mehmet Ali, Olmez, Omer Fatih, Acikgoz, Ozgur, Cicin, Irfan
Publicado 2023